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SUMMARY
Treatmentofurinary incontinence with theartificial urinarysphincterhasbeen
available in centres such as London and Liverpool fora numberofyears. This
service is now available in the department of urology of the Belfast City
Hospital. Twelve patients have had successful implantation of an artificial
urinary sphincter for urinary incontinence, and ten are now fully continent.
One patient with Wegener's granulomatosis developed active disease in his
urethra which hasprecluded activation ofthe device. Onepatient has had the
device removed because oferosion into the urethra.
INTRODUCTION
Urinary incontinence is a distressing condition which can have profound
psychological effects on the patient, leading to social withdrawal and loss ofself
esteem. The financial consequences of conventional lifelong treatment of
incontinence (pads and catheters) are enormous. The majority of patients
suffering from urinary incontinence are female who usually respond to a bladder
necksuspensionprocedure. Malepatientsandpatientswithneuropathicbladders
need a more sophisticated approach to the problem l,
In 1973 Scott 3 implanted the first artificial urinary sphincter and since then the
device has undergone modifications to make it more reliable and easier to use.
Theadvantage ofthecurrentmodelisthatitcan beleftin a deactivatedstateuntil
tissuehealing iscompletethusminimisingtheriskofdeviceerosion.Wedescribe
our experience of 12 patients who had the American Medical Systems model
800TM (AMS 800) artificial sphincter inserted in a two year period.
PATIENTS AND METHODS
Twelve patients age range 19-76 (mean 48) have been treated. The clinical
diagnosis, urodynamic findings and adjunctive surgical procedures for eleven
are summarised in the table. All patients were assessed by clinical examination
and endoscopy of the lower urinary tract. All patients had video urodynamics
performed using the Aspen Medical, GaelTech GR 800 urodynamic system.
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Bladder capacity, intravesical pressure, and urethral pressure profiles were
measured. The mechanics ofthe device were explained in detail to the patient,
and those with neuropathic incontinence were shown how to perform clean
intermittent self catheterisation.
The patients were admitted for preoperative bowel preparation. Triple antibiotic
therapy (gentamicin, metronidazole and penicillin) is continued for five days
postoperatively. In males the device can be inserted around the bulbar urethra,
the membranous urethra or aroundthe bladderneck. In the female it can only be
placedaroundthebladderneck. Thereservoirdeterminesthepressureinthecuff
and a variety ofpressures (40-50,51-60,61-70, 71-80 cm H20) can beachieved
using different reservoirs. (Fig 1).
Fig 1. The artificial urinary sphincter. (a) The reservoir. (b) The pump. (c) The cuffwhich is inserted
around the urethra or bladder neck.
To implant an artificial urinary sphincter around the bulbar urethra, an incision
is made in the perineum and the bulbar urethra is mobilised with the
bulbospongiosus muscle. A measuring device is used to select the correct size
ofcuff. A second incision is made in either iliacfossa, andthe reservoir is placed
deep to the rectus abdominis in an extraperitoneal position. A subcutaneous
tunnel is made into the scrotum, and the pump mechanism placed in a
subcutaneous position. In the female the pump mechanism is placed in the
labium majus. The device is filled with an isotonic radio-opaque solution taking
great care not to allow any contamination of the tubing with blood or air.
Ifthedevice isplacedaroundthebladderneck asuprapubicapproachisrequired
(Fig 2). The procedure is technically difficult as there is a risk of entering the
vagina in the female or the rectum in the male. If this complication occurs the
procedure must be abandoned.
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Fig 2. An artificial urinary sphincter in situ
around the bladder neck of a patient with
spina bifida.
RESULTS
Eleven patients have had successful
insertion ofthe artificial sphincter. Ten are
fully continent and using the device
successfully. One patient's urethra was
damaged during mobilisation, and the
devicesubsequentlyerodedintotheurethra
and had to be removed. One patient who
had Wegener's granulomatosis of the
prostate and bladder neck developed a
dense urethral stricture three months after
insertion of the artificial sphincter. The
stricture was biopsied which confirmed
the presence of active Wegener's
granulomatosis. Heiscurrentlyundergoing
treatment and the sphincter has been left
deactivated. Hewill requireaurethroplasty
to maintain urethral patency. One patient
with sDina bifida who had mild stress
incontinence postoperatively has had a further procedure to insert a higher
pressure reservoir and is now dry.
Patient Diagnosis Cystometry Sphincter Adjunctive
procedure
I Post prostatectomy Unstable Weak Cystoplasty
2 Post prostatectomy Stable Weak
3 Post prostatectomy Stable Weak
4 Post prostatectomy Stable Weak
5 Post prostatectomy Stable Weak
6 Post prostatectomy Stable Weak
7 Carcinoma prostate Stable Weak Cystoplasty
Small capacity
8 Wegener's Stable Weak Cystoplasty
granulomatosis Small capacity Urethrotomy
9 Spina bifida Stable Weak Cystoplasty
Small capacity
10 Spina bifida Stable Weak
11 Spina bifida Stable Weak Urethrotomy
Table. Details of 11 patients who have had successful insertion of an
artificial urinary sphincter.
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DISCUSSION
Patients selectedforimplantation ofan artificial urinarysphincterhaveoneofthe
following conditions: post-prostatectomy incontinence, failed surgery for stress
incontinence, neuropathic bladder, congenital abnormalities ofthe urinary tract
or post-traumatic injury. Careful selection is essential if optimum results are to
be obtained. The patients must be highly motivated and intelligent enough to
understand the workings of the device, and be prepared to undergo more than
one surgical procedure to attain continence.
The artificial sphincter is designed to produce a bladder outlet resistance in the
range of pressures as described above. The design of the device allows rises in
intra-abdominal pressure to be transmitted to the cuff. This usually occurs
relatively slowly, but if intra-abdominal pressure rises very quickly, as when
getting up from a low chair, slight stress incontinence may occur. This has an
importantbearingonpatientselection, aspatientswithspina bifida inwheelchairs
generate high intra-abdominal pressures when trying to move themselves in the
wheelchair, asdothosewhowalkwithelbowcrutches. Pre-operative assessment
ofthe patient, treatment of any urinary tract infection, dermatitis or other foci of
infection is essential before inserting the device.
Patients should be prepared to perform clean intermittent self-catheterisation if
necessary. This is an important part of the management of the neuropathic
bladder to eliminate residual urine consequent on inefficient bladder emptying.
After insertion ofan artificial urinary sphincter in patients with neuropathy, or in
those who have had a cystoplasty, bladder emptying may be further impaired
andsomepatientsmayneedtoperformself-catheterisationthroughthesphincter
cuff to eliminate residual urine.
Video urodynamics are essential to accurately measure bladder pressure,
capacity and sphincter function . The anatomy ofthe bladder and bladder neck
can be visualised and vesicoureteric reflux identified 4. Careful endoscopy is
neededto ensurethatthe patient's urethra is normal and any stricture or urethral
disease should be treated before inserting the device. The bladder must be of
adequatecapacitytoallowthepatienttoholdurineforasociallyacceptabletime.
The bladder must also be capable of storing urine at low pressure in order to
protectthe upperrenal tracts. Itis imperative totreat anydetrusorinstability with
anticholinergics. Ifmedicaltreatmentofinstabilityfailsthenthesurgicalprocedure
ofchoiceisanileocystoplasty (the"clam"procedure). The"clam"ileocystoplasty
involves opening the bladder like an open clamshell and suturing in a patch of
ileum, which has the combined effect of increasing bladder capacity and
5 reducingg bladder pressure
Patients with post-prostatectomy injury, or following trauma, usually have pure
sphincter weakness. Patients with neuropathic disorders, those following failed
stress incontinence surgery, orthosewithcongenital abnormalitiesoftheurinary
tract are more complex and may require a variety of adjunctive procedures.
The major complication following implantation is infection leading to erosion. If
thisoccurs, thedevice mustberemoved, ashealingwill notoccurinthe presence
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of a foreign body. Mundy2 has identified patients who are at risk for this and
quotes 15% infection erosion rate in patients with neuropathic bladders. In
patientswhohavehada slingoperation aroundthebladderneckorin anypatient
who has had pelvic radiotherapy the infection erosion rate is over 50%. Thus,
previous sling surgery or radiotherapy is a contra-indication to insertion of an
artificial urinary sphincter6' 7. Erosion rates are higherin elderly patients orwhen
thedeviceisimplanted aroundthebulbarurethra asopposedtothebladderneck.
Although implantation around the bladder neck has a lower rate of erosion, the
operative procedure is more difficult and is associated with greater morbidity.
Patients with incontinence as a result ofmajortrauma may have such extensive
fibrosis atthebladderneckastoprecludeimplantation atthissite. Erosionis also
more frequent when higher pressure reservoirs are used and it is our practice to
implant a low pressure reservoir initially, changing to a higher pressure if
incontinence persists.
The major alternative to implantation of an artificial urinary sphincter is
reconstruction of the bladder neck or a urinary diversion. Continent urinary
diversions are associated with a high complication rate, with the obvious
disadvantages of needing a stoma which has to be catheterised. Successful
implantation ofan artificial sphincteroffers a betterqualityoflife. Thisprocedure
does not have a place in the first line of treatment of stress incontinence in
femalesandisonlyusedforcomplexcasesfollowingfailedanti-stressprocedures.
The overall success rate ofthe artificial urinary sphincter is about 95%, with 5%
being persistent failures. The major complications are infection and erosion,
which occur in 10%-15% of patients. Two percent of the devices develop early
mechanical failure and a further 2% develop late longterm failures usually due to
leakage from the cuff.
Our experience indicates thatwith careful patient selection excellent results can
be achieved with the artificial urinary sphincter. It is the procedure ofchoice for
patientswith post-prostatectomy incontinence. Itisidealforcertain patientswith
neuropathic bladder dysfunction who are highly motivated and have normal
hand function.
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